SPARC gets USFDA approval to treat Leukemia
SPARC gets USFDA approval to treat Leukemia

SPARC gets USFDA approval to treat Leukemia

Nidhi Jani Article rating: 4.7

Orphan Drug Designation will grant seven years of US market exclusivity upon approval of SCO-088 for the treatment of patients with CML. Incentives include waiver of user fee by USFDA and assistance in clinical trial design by USFDA.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 3.3

Overall volumes in futures & options currently stand at 1,43,24,430 contracts with a turnover of Rs.10,46,886.87 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1,43,24,430 contracts with a turnover of Rs.10,46,886.87 crore.

Index trend and stocks in action July 08, 2019
Index trend and stocks in action July 08, 2019

Index trend and stocks in action July 08, 2019

Karan Dsij Article rating: 5.0

It would be interesting to see whether or not bulls manage to hold on to the budget session low of (11,798). If they manage to hold above this level, the pullback options would remain open towards the levels of 11,880-11,940. However, failure to hold the support level of 11,798 would result in a prolonged correction towards the next important support level of 11,726, which is 50-DMA. Stocks in news: India Grid Trust, PNB Housing, PNB, Indian Hume Pipe, JSW Energy, Zuari Agro Chemicals, Yes Bank, Quick Heal Technologies, Tata Power, JSW Steel, Maruti Suzuki.

A weak start likely amid negative global cues
A weak start likely amid negative global cues

A weak start likely amid negative global cues

Karan Dsij Article rating: 5.0

The global markets are trading in the negative terrain and the SGX Nifty is indicating a soft opening at 11,772, a mark down by 45 points.

Jamna Auto Industries showcases good growth potential
Jamna Auto Industries showcases good growth potential

Jamna Auto Industries showcases good growth potential

Dnyanada Kulkarni Article rating: 3.3

Jamna Auto Industries Ltd. (JAI) is a manufacturer of auto suspension products such as parabolic/tapered leaf spring, lift axle and air suspension. It operates in the OEM and CV segment.

RSS
First22942295229622972299230123022303Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR